Mark P. Colonnese

2018 - Biota Pharmaceuticals

In 2018, Mark P. Colonnese earned a total compensation of $639.4K as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals, a 5% increase compared to previous year.

Compensation breakdown

Salary$43,725
Other$595,656
Total$639,381

Colonnese received $595.7K in other compensation, accounting for 93% of the total pay in 2018.

Colonnese also received $43.7K in salary.

Rankings

In 2018, Mark P. Colonnese's compensation ranked 11,049th out of 14,244 executives tracked by ExecPay. In other words, Colonnese earned more than 22.4% of executives.

ClassificationRankingPercentile
All
11,049
out of 14,244
22nd
Division
Manufacturing
4,455
out of 5,762
23rd
Major group
Chemicals And Allied Products
1,690
out of 2,125
21st
Industry group
Drugs
1,434
out of 1,814
21st
Industry
Biological Products, Except Diagnostic Substances
277
out of 339
18th
Source: SEC filing on March 11, 2019.

Colonnese's colleagues

We found four more compensation records of executives who worked with Mark P. Colonnese at Biota Pharmaceuticals in 2018.

2018

Joseph Patti

Biota Pharmaceuticals

Chief Executive Officer

2018

Wouter Latour

Biota Pharmaceuticals

Chief Executive Officer

2018

John Harland

Biota Pharmaceuticals

Chief Financial Officer

2018

Sean Tucker

Biota Pharmaceuticals

Chief Scientific Officer

News

You may also like